Joseph P. Ornato
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Joseph P. Ornato has a total of 135 co-authors. Here are the top co-authors by number of shared publications:
- Gavin D. Perkins
Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK
11 shared publications - Jasmeet Soar
Southmead Hospital, North Bristol NHS Trust, Bristol, UK
11 shared publications - Jerry P. Nolan
Warwick Medical School, University of Warwick, Coventry, UK
11 shared publications - Michael Parr
Intensive care unit, Liverpool Hospital, Sydney, Australia; University of New South Wales, Sydney, Australia
11 shared publications Mary Ann Peberdy
Virginia Commonwealth University Health Department of Emergency Medicine, Richmond, Virginia
5 shared publications- Mary Ann Peberdy
Weil Institute of Emergency and Critical Care Research, Virginia Commonwealth University, Richmond, VA
3 shared publications
Latest Publications
- Open Access
- 31 October 2022
- Published by Wolters Kluwer Health in Shock
- Vol. 58 (6) , 573-581
IVABRADINE-INDUCED HEART RATE REDUCTION INCREASES THE SEVERITY OF POSTRESUSCITATION MYOCARDIAL DYSFUNCTION IN A RAT MODEL OF CARDIOPULMONARY RESUSCITATION
Aims: A rapid heart rate (HR) that occurs after cardiopulmonary resuscitation (CPR) is a short-term compensatory mechanism preserving cardiac output. However, if of long duration, it is unfavorable for myocardial function postresuscitation because of disrupted balance between myocardial oxygen supply and demand. This raises the assumption that such a sustained fast HR should be regulated. The present study aimed to investigate the follow-on effect of ivabradine (a specific inhibitor of the If current of the sinoatrial node)–induced HR reduction (HRR) on postresuscitation myocardial function in a rat model of CPR. Methods and results: Six minutes of ventricular fibrillation and 8 min of CPR were performed on Sprague-Dawley rats. All 32 resuscitated animals were then randomized into saline and ivabradine groups, each group having nonsurvival and survival subgroups (n = 8 each). Saline or ivabradine (0.5 mL/kg) was administered at 1 h postresuscitation. Heart rate, myocardial function as expressed by cardiac output, ejection fraction, and myocardial performance index were assessed at baseline and hourly from 1 to 5 h postresuscitation. Heart rate variability was analyzed at baseline and at 1, 3, and 5 h postresuscitation. Serum epinephrine and cardiac troponin I at baseline and at 1, 3, and 5 h postresuscitation in nonsurvival subgroup were measured. Survival duration in the survival subgroup was observed. The baseline HR was approximately 390 beats/min (bpm). After resuscitation, an average increase of Δ ≈ +15 bpm (relative ratio ≈ +3.8%) with a resultant HR of 405 bpm lasting more than 5 h occurred. Ivabradine group achieved a steady HRR of Δ ≈ −30 bpm (relative ratio ≈ −7.4%) as compared with saline group (P < 0.01). Postresuscitation myocardial function was significantly worse in the ivabradine group (all P < 0.01). Heart rate variability was significantly impaired in the ivabradine group (all P < 0.05). Serum cardiac troponin I and epinephrine concentration were significantly higher in the ivabradine group (all P < ?0.01). Survival duration was significantly shortened in the ivabradine group as compared with the saline group (388 vs. 526 min, P < ?0.01). Conclusions: Ivabradine-induced HRR increases the severity of postresuscitation myocardial dysfunction and shortens survival duration in a rat model of CPR.
- 31 October 2022
- Published by Wolters Kluwer Health in Shock
- Vol. 58 (6) , 573-581
Open AccessIVABRADINE-INDUCED HEART RATE REDUCTION INCREASES THE SEVERITY OF POSTRESUSCITATION MYOCARDIAL DYSFUNCTION IN A RAT MODEL OF CARDIOPULMONARY RESUSCITATION
Aims: A rapid heart rate (HR) that occurs after cardiopulmonary resuscitation (CPR) is a short-term compensatory mechanism preserving cardiac output. However, if of long duration, it is unfavorable for myocardial function postresuscitation because of disrupted balance between myocardial oxygen supply and demand. This raises the assumption that such a sustained fast HR should be regulated. The present study aimed to investigate the follow-on effect of ivabradine (a specific inhibitor of the If current of the sinoatrial node)–induced HR reduction (HRR) on postresuscitation myocardial function in a rat model of CPR. Methods and results: Six minutes of ventricular fibrillation and 8 min of CPR were performed on Sprague-Dawley rats. All 32 resuscitated animals were then randomized into saline and ivabradine groups, each group having nonsurvival and survival subgroups (n = 8 each). Saline or ivabradine (0.5 mL/kg) was administered at 1 h postresuscitation. Heart rate, myocardial function as expressed by cardiac output, ejection fraction, and myocardial performance index were assessed at baseline and hourly from 1 to 5 h postresuscitation. Heart rate variability was analyzed at baseline and at 1, 3, and 5 h postresuscitation. Serum epinephrine and cardiac troponin I at baseline and at 1, 3, and 5 h postresuscitation in nonsurvival subgroup were measured. Survival duration in the survival subgroup was observed. The baseline HR was approximately 390 beats/min (bpm). After resuscitation, an average increase of Δ ≈ +15 bpm (relative ratio ≈ +3.8%) with a resultant HR of 405 bpm lasting more than 5 h occurred. Ivabradine group achieved a steady HRR of Δ ≈ −30 bpm (relative ratio ≈ −7.4%) as compared with saline group (P < 0.01). Postresuscitation myocardial function was significantly worse in the ivabradine group (all P < 0.01). Heart rate variability was significantly impaired in the ivabradine group (all P < 0.05). Serum cardiac troponin I and epinephrine concentration were significantly higher in the ivabradine group (all P < ?0.01). Survival duration was significantly shortened in the ivabradine group as compared with the saline group (388 vs. 526 min, P < ?0.01). Conclusions: Ivabradine-induced HRR increases the severity of postresuscitation myocardial dysfunction and shortens survival duration in a rat model of CPR.
- 27 July 2022
- Published by Taylor & Francis in Prehospital Emergency Care
- Vol. 27 (7) , 1-25
Importance of Analyzing Intervals to Emergency Medical Service Treatments
Background Although most US emergency medical services (EMS) systems collect time-to-treatment data in their electronic prehospital patient care reports (PCRs), analysis of these data seldom appears in publications. We believe EMS agencies should routinely analyze at least the initial time-to-treatment data for various potentially life-threatening conditions on quality review. This step not only assures that protocol-required treatments have been provided but can discover avoidable delays and, when necessary, drive protocol and treatment priority change. The purpose of this study was to analyze the interval from 9-1-1 call receipt until the first administration of naloxone to adult opioid overdose victims to demonstrate the quality assurance importance of analyzing time-to-treatment data. Method Retrospective analysis of times from 9-1-1 call receipt to initial naloxone treatment in adult opioid overdose victims treated by EMS personnel in Richmond, VA, between 1/1/19 and 10/24/21. The analysis excluded victims <18 years of age and cases where a bystander, police, or a health care worker gave naloxone before EMS arrival. We compared data collected before and during the COVID-19 pandemic to determine any effect it may have had on the analysis. Results A total of 582 opioid overdose cases were analyzed. The mean patient age was 40.7 years [95% CI 39.6, 41.8], and 405 were males (69.6%). EMS units arrived at the scene in 6.7 minutes from the 9-1-1 call receipt. It took 1.8 minutes to reach the victim, and 8.6 additional minutes to administer the first naloxone regardless of administration route (70.4% intravenous, 26.1% intranasal, 2.7% intraosseous, 0.7% intramuscular). EMS personnel administered the first naloxone 17.1 minutes after the 9-1-1 call receipt, with 50.3% of the delay occurring after EMS contacted the patient. There was no statistically significant difference in the times-to-treatment before vs. during the pandemic. Conclusion The interval from 9-1-1 call receipt until initial EMS administration of naloxone was substantial during our analysis period and did not change significantly during the COVID-19 pandemic. We believe our findings provide an important example that supports why EMS agencies should analyze initial time-to-treatment data, especially for life-threatening conditions, beyond assuring that protocol-required treatments have been provided. Based on our analysis, fire department crews now carry intranasal naloxone, and intranasal naloxone is given to “impaired" opioid overdose victims by either fire department or EMS personnel, whoever arrives first. We are continuing to collect data on intervals-to-treatment prospectively and monitoring our critical process and treatment intervals. We are using the plan-do-study-act model for improving our process and carrying out a change. We plan to share our results in a future publication once we have sufficient data.
- 27 July 2022
- Published by Taylor & Francis in Prehospital Emergency Care
- Vol. 27 (7) , 1-25
Importance of Analyzing Intervals to Emergency Medical Service Treatments
Background Although most US emergency medical services (EMS) systems collect time-to-treatment data in their electronic prehospital patient care reports (PCRs), analysis of these data seldom appears in publications. We believe EMS agencies should routinely analyze at least the initial time-to-treatment data for various potentially life-threatening conditions on quality review. This step not only assures that protocol-required treatments have been provided but can discover avoidable delays and, when necessary, drive protocol and treatment priority change. The purpose of this study was to analyze the interval from 9-1-1 call receipt until the first administration of naloxone to adult opioid overdose victims to demonstrate the quality assurance importance of analyzing time-to-treatment data. Method Retrospective analysis of times from 9-1-1 call receipt to initial naloxone treatment in adult opioid overdose victims treated by EMS personnel in Richmond, VA, between 1/1/19 and 10/24/21. The analysis excluded victims <18 years of age and cases where a bystander, police, or a health care worker gave naloxone before EMS arrival. We compared data collected before and during the COVID-19 pandemic to determine any effect it may have had on the analysis. Results A total of 582 opioid overdose cases were analyzed. The mean patient age was 40.7 years [95% CI 39.6, 41.8], and 405 were males (69.6%). EMS units arrived at the scene in 6.7 minutes from the 9-1-1 call receipt. It took 1.8 minutes to reach the victim, and 8.6 additional minutes to administer the first naloxone regardless of administration route (70.4% intravenous, 26.1% intranasal, 2.7% intraosseous, 0.7% intramuscular). EMS personnel administered the first naloxone 17.1 minutes after the 9-1-1 call receipt, with 50.3% of the delay occurring after EMS contacted the patient. There was no statistically significant difference in the times-to-treatment before vs. during the pandemic. Conclusion The interval from 9-1-1 call receipt until initial EMS administration of naloxone was substantial during our analysis period and did not change significantly during the COVID-19 pandemic. We believe our findings provide an important example that supports why EMS agencies should analyze initial time-to-treatment data, especially for life-threatening conditions, beyond assuring that protocol-required treatments have been provided. Based on our analysis, fire department crews now carry intranasal naloxone, and intranasal naloxone is given to “impaired" opioid overdose victims by either fire department or EMS personnel, whoever arrives first. We are continuing to collect data on intervals-to-treatment prospectively and monitoring our critical process and treatment intervals. We are using the plan-do-study-act model for improving our process and carrying out a change. We plan to share our results in a future publication once we have sufficient data.
- Open Access
- 22 January 2022
- Published by Elsevier in Resuscitation
- Vol. 172, 64-73
Resuscitation highlights in 2021
- 22 January 2022
- Published by Elsevier in Resuscitation
- Vol. 172, 64-73
Open AccessResuscitation highlights in 2021
- 1 March 2021
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 41, 60-65
Delay to initiation of out-of-hospital cardiac arrest EMS treatments
- 1 March 2021
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 41, 60-65
Delay to initiation of out-of-hospital cardiac arrest EMS treatments
- 1 March 2020
- Published by Elsevier in Resuscitation
- Vol. 148, 234-241
Resuscitation highlights in 2019
- 1 March 2020
- Published by Elsevier in Resuscitation
- Vol. 148, 234-241
Resuscitation highlights in 2019
- 1 February 2019
- Published by Elsevier in Resuscitation
- Vol. 135, 168-175
Resuscitation highlights in 2018
- 1 February 2019
- Published by Elsevier in Resuscitation
- Vol. 135, 168-175
Resuscitation highlights in 2018
- 1 August 2018
- Published by Elsevier in Resuscitation
- Vol. 129, e12-e13
How to determine whether to perform chest compressions on an unconscious patient with an implanted left ventricular assist device
- 1 August 2018
- Published by Elsevier in Resuscitation
- Vol. 129, e12-e13
How to determine whether to perform chest compressions on an unconscious patient with an implanted left ventricular assist device
- 6 February 2018
- Published by Elsevier in Resuscitation
- Vol. 125, 99-103
Non-invasive characterization of hemodynamics in adult out-of-hospital cardiac arrest patients soon after return of spontaneous circulation
- 6 February 2018
- Published by Elsevier in Resuscitation
- Vol. 125, 99-103
Non-invasive characterization of hemodynamics in adult out-of-hospital cardiac arrest patients soon after return of spontaneous circulation